Biotics Eltacin tablets sublingual No. 30

Release form - sublingual tablets.

Packaging - 30 tablets.

pharmachologic effect

Eltacin is a combined preparation that contains a mixture of nonessential amino acids: glycine, glutamic acid and cystine, which are metabolism regulators: they increase the intracellular concentration of glutathione and the activity of glutathione-dependent enzymes, normalize redox processes and oxygen utilization in tissues, due to which the drug:

exhibits antioxidant (reducing the content of free radicals, peroxide compounds, malondialdehyde) and antihypoxant (increasing the body's resistance to oxygen deficiency, enhancing the synthesis of adenosine triphosphoric acid (ATP)) action

increases myocardial contractility

increases physical performance

improves the quality of life of patients with chronic heart failure (increasing social adaptation, improving psycho-emotional state)

accelerates the recovery of working capacity after intense physical activity in children.

Indications

Chronic heart failure I-III functional class according to NYHA classification in adults (against the background of standard therapy).

Chronic heart failure I-II functional class according to NYHA classification in children aged 12 to 18 years (against the background of standard therapy).

Autonomic dysfunction syndrome in children aged 12 to 18 years.

Prevention of chronic physical stress and recovery after intense physical exertion when playing sports in children aged 11 to 15 years.

Contraindications

: hypersensitivity to the drug Eltacin, children under 11 years of age (efficacy and safety have not been established).

Application during pregnancy and lactation

Clinical studies of the use of the drug in pregnant women and during lactation have not been conducted.

Not recommended for use during pregnancy and lactation.

Structure

1 sublingual tablet contains:

active substances: glycine 70 mg, L-glutamic acid 70 mg, L-cystine 70 mg,

excipients: water-soluble methylcellulose 7.8 mg

magnesium stearate 2.2 mg.

Method of administration and dosage

Eltacin is taken sublingually.

The tablet can also be chewed and held in the mouth under the tongue until it is completely dissolved.

Chronic heart failure I-III functional class according to NYHA classification in adults: 1 tablet 3 times a day sublingually, the course of treatment is from 1 to 3 months, depending on the severity of the disease, repeated courses are prescribed on the recommendation of a doctor.

Chronic heart failure of I-II functional class according to NYHA classification in children aged 12 to 18 years: 1 tablet 3 times a day sublingually, the course of treatment is from 1 to 3 months, depending on the severity of the disease, repeated courses are prescribed on the recommendation of a doctor.

Autonomic dysfunction syndrome in children aged 12 to 18 years: 1 tablet 3 times a day sublingually, the course of treatment is from 1 to 3 months, depending on the severity of the disease, repeated courses are prescribed on the recommendation of a doctor.

Prevention of chronic physical stress in children aged 11 to 15 years: 1 tablet 2 times a day for 2-3 weeks.

During the recovery period after intense physical activity when playing sports in children aged 11 to 15 years - 1 tablet 3 times a day for 2 weeks.

Side effects

: Allergic reactions are possible.

Drug interactions

: can be taken simultaneously with angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, aldosterone antagonists, organic nitrates and slow calcium channel blockers.

Storage conditions

: in a dry, dark place and out of reach of children, at a temperature not exceeding 25 В° C.

Shelf life

: 3 years.

Active substance

: glycine, glutamic acid, cystine.

Name ENG

ELTACIN

Clinical and pharmacological group

A drug that normalizes myocardial metabolism, reduces tissue hypoxia

ATX code

Other combination drugs for the treatment of heart disease

Dosage

70mg + 70mg + 70mg

Structure

1 sublingual tablet contains active substances: glycine 70 mg, L-glutamic acid 70 mg, L-cystine 70 mg

excipients: water-soluble methylcellulose 7.8 mg

magnesium stearate 2.2 mg.

Indications

Chronic heart failure I-III functional class according to NYHA classification in adults (against the background of standard therapy) Chronic heart failure of functional class I-II according to NYHA classification in children aged 12 to 18 years (against the background of standard therapy) Autonomic dysfunction syndrome in children aged 12 to 18 years. Prevention of chronic physical stress and recovery after intense physical exertion when playing sports in children aged 11 to 15 years.

INN / Active ingredient

Glycine, Glutamic acid, Cystine

Storage conditions and periods

At a temperature not exceeding 25 degrees, in the original packaging.

Expiration date: 3 years

Specifications

Scope of the drug

Neurology, psychiatry

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

thirty

Scope of application

Cardiology

Minimum age from

11 years

Way of introduction

Under the tongue

Vacation conditions

Without recipe

Brand name

Biotics Mnpk

The amount of the dosage form in the primary package

30 pcs.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Antioxidant

Dosage form

Sublingual tablets

Dosage (volume) of the substance in the preparation

glycine 70 mg, glutamic acid 70 mg, cystine 70 mg

Expiration date in days

1095

The target audience

Children

Package weight, g

32

Category

:

Mental strain

,

Memory impairment

,

Neuroprotective agents

,

Nootropic drugs

Mode of application

:

Eltacin is taken sublingually. The tablet can also be chewed and held in the mouth under the tongue until it is completely dissolved. Chronic heart failure I-III functional class according to NYHA classification in adults: 1 tablet 3 times a day sublingually, the course of treatment is from 1 to 3 months, depending on the severity of the disease, repeated courses are prescribed on the recommendation of a doctor. Chronic heart failure of I-II functional class according to NYHA classification in children aged 12 to 18 years: 1 tablet 3 times a day sublingually, the course of treatment is from 1 to 3 months, depending on the severity of the disease, repeated courses are prescribed on the recommendation of a doctor. Autonomic dysfunction syndrome in children aged 12 to 18 years: 1 tablet 3 times a day sublingually, the course of treatment is from 1 to 3 months, depending on the severity of the disease,repeated courses are prescribed on the recommendation of a doctor. Prevention of chronic physical stress in children aged 11 to 15 years: 1 tablet 2 times a day for 2-3 weeks. During the recovery period after intense physical activity when playing sports in children aged 11 to 15 years - 1 tablet 3 times a day for 2 weeks.

Anatomical and therapeutic characteristics

:

C01EX Combined drugs for the treatment of heart diseases

Information on technical characteristics, delivery set, country of manufacture